Skip to main content

Mark Massaro

Analyst

US Bancorp / BTIG

Equibles does not estimate personal net worth.

About Mark Massaro

Mark Massaro is recorded as Analyst at US Bancorp / BTIG. Mark Massaro has spoken on 3 earnings calls across 3 companies, most recently for Exagen Inc. on November 10, 2026. Those appearances were for Exagen Inc. (XGN), Freenome, Inc. (FRNM) and BillionToOne, Inc. (BLLN). The companies whose calls Mark Massaro spoke on are classified in the Healthcare sector.

Mark Massaro on recent calls

“You know, to what extent do you think you can answer additional clinical questions to the rheumatologist? I presume this test is for the aid in to diagnose myositis, but I'm wondering if there are any other clinical questions this test can enable you to answer across autoimmune disease.”
Analyst — US Bancorp / BTIG, Q3 2026 Earnings Call ·
“And it sounds like, you know, you talked about the 20 individuals calling on health systems for lung. Is that the size of your total?”
Analyst — US Bancorp / BTIG, Freenome, Inc. Q3 FY2026 Earnings Call ·
“I do like the branding of the name of the test. You know, other companies in the space, when they launch an MRD test, that's not reimbursed. We've seen others sort of manage the volume growth in order to... So I wanted to just ask, maybe can you walk us through your plan?”
Analyst — US Bancorp / BTIG, BillionToOne 3Q26 Earnings Call ·

Affiliation history

  • US Bancorp / BTIG

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity